腹腔镜直肠癌经括约肌间切除术后顽固性吻合口狭窄的影响因素及列线图预测模型构建

Influencing factors of refractory anastomotic stenosis after laparoscopic intersphincteric resec-tion for rectal cancer and construction of nomogram prediction model

  • 摘要:
    目的 探讨腹腔镜直肠癌经括约肌间切除术(Ls‑ISR)后发生顽固性吻合口狭窄的影响因素及列线图预测模型构建。
    方法 采用回顾性病例对照研究方法。收集2012年6月至2021年12月2家医学中心收治的495例(北京大学第一医院448例、中国医学科学院肿瘤医院47例)行Ls‑ISR患者的临床病理资料;男311例,女184例;年龄为61(20~84)岁。观察指标:(1)吻合口狭窄发生情况。(2)影响Ls‑ISR后发生顽固性吻合口狭窄的因素分析。(3)Ls‑ISR后发生顽固性吻合口狭窄列线图预测模型构建及评价。采用门诊、电话等方式进行随访,了解患者术后吻合口漏和吻合口狭窄情况。随访时间截至2022年8月。正态分布的计量资料以x±s表示,组间比较采用t检验;偏态分布的计量资料以M(范围)表示。计数资料以绝对数表示,组间比较采用χ²检验。单因素和多因素分析均采用Logistic回归模型。将单因素分析中P<0.10的因素纳入多因素分析。采用R软件(3.6.3)构建列线图预测模型。绘制受试者工作特征曲线,以曲线下面积评价效能。
    结果 (1)吻合口狭窄发生情况。495例患者均施行Ls‑ISR,无中转开腹。495例患者术后均获得随访,随访时间为47(8~116)个月。495例患者随访期间,458例未发生吻合口狭窄、37例发生吻合口狭窄。37例发生吻合口狭窄患者中,A级15例、B级3例、C级19例;其中22例为顽固性狭窄。15例A级吻合口狭窄患者扩肛治疗后缓解;3例B级吻合口狭窄患者经球囊扩张及内镜治疗好转;19例C级吻合口狭窄患者行永久性肠造口术。495例患者随访期间,发生吻合口漏42例(17例顽固性吻合口狭窄);未发生吻合口漏453例(5例顽固性吻合口狭窄),发生吻合口漏和未发生吻合口漏患者中顽固性吻合口狭窄比较,差异有统计学意义(χ²=131.181,P<0.05)。(2)影响Ls‑ISR后发生顽固性吻合口狭窄的因素分析。多因素分析结果显示:行新辅助治疗、肿瘤距肛缘距离≤4 cm、临床N分期为N+是影响Ls‑ISR后发生顽固性吻合口狭窄的独立危险因素(风险比=7.297,3.898,2.672,95%可信区间为2.870~18.550,1.050~14.465,1.064~6.712,P<0.05)。(3)Ls‑ISR后发生顽固性吻合口狭窄列线图预测模型构建及评价。根据多因素分析结果,纳入新辅助治疗、肿瘤距肛缘距离、临床N分期,构建Ls‑ISR后顽固性吻合口狭窄发生风险的列线图预测模型。受试者工作特征曲线结果显示:Ls‑ISR后发生顽固性吻合口狭窄列线图预测模型的曲线下面积为0.739(95%可信区间为0.646~0.833)。
    结论 行新辅助治疗、肿瘤距肛缘距离≤4 cm、临床N分期为N+是影响Ls‑ISR后发生顽固性吻合口狭窄的独立危险因素,其列线图预测模型可预测患者术后顽固性吻合口狭窄发生率。

     

    Abstract:
    Objective To investigate the influencing factors of refractory anastomotic stenosis after laparoscopic intersphincteric resection (Ls-ISR) for rectal cancer and construction of nomogram prediction model.
    Methods The retrospective case-control study was conducted. The clinicopatho-logical data of 495 patients who underwent Ls-ISR for rectal cancer in two medical centers, including 448 patients in Peking University First Hospital and 47 patients in Cancer Hospital Chinese Academy of Medical Sciences, from June 2012 to December 2021 were collected. There were 311 males and 184 females, aged 61 (range, 20-84)years. Observation indicators: (1) incidence of anastomotic stenosis; (2) influencing factors of refractory anastomotic stenosis after Ls-ISR; (3) construction and evaluation of nomogram prediction model for refractory anastomotic stenosis after Ls-ISR. Follow-up was conducted using outpatient examination and telephone interview to detect the incidence of postoperative anastomotic leakage and anastomotic stenosis up to August 2022. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was conducted using the t test. Measurement data with skewed distribution were represented as M(range). Count data were described as absolute numbers, and comparison between groups was conducted using the chi-square test. Univariate and multivariate analyses were conducted using the Logistic regression model. Factors with P<0.10 in univariate analysis were included in multivariate analysis. The R software (3.6.3 version) was used to construct nomogram prediction model. The receiver operating characteristic (ROC) curve was drawn and the area under curve (AUC) was used to evaluate the efficacy of nomogram prediction model.
    Results (1) Incidence of anastomotic stenosis. All 495 patients underwent Ls-ISR successfully, without conversion to laparotomy, and all patients were followed up for 47(range, 8-116)months. During the follow-up period, there were 458 patients without anas-tomotic stenosis, and 37 patients with anastomotic stenosis. Of the 37 patients, there were 15 cases with grade A anastomotic stenosis, 3 cases with grade B anastomotic stenosis and 19 cases with grade C anastomotic stenosis, including 22 cases being identified as the refractory anastomotic stenosis. Fifteen patients with grade A anastomotic stenosis were relieved after anal dilation treat-ment. Three patients with grade B anastomotic stenosis were improved after balloon dilation and endoscopic treatment. Nineteen patients with grade C anastomotic stenosis underwent permanent stoma. During the follow-up period, there were 42 cases with anastomotic leakage including 17 cases combined with refractory anastomotic stenosis, and 453 cases without anastomotic leakage including 5 cases with refractory anastomotic stenosis. There was a significant difference in the refractory anastomotic stenosis between patients with and without anastomotic leakage (χ2=131.181, P<0.05). (2) Influencing factors of refractory anastomotic stenosis after Ls-ISR. Results of multivariate analysis showed that neoadjuvant therapy, distance from tumor to anal margin ≤4 cm, clinic N+ stage were independent risk factors of refractory anastomotic stenosis after Ls-ISR (hazard ratio=7.297, 3.898, 2.672, 95% confidence interval as 2.870-18.550, 1.050-14.465, 1.064-6.712, P<0.05). (3) Construction and evaluation of nomogram prediction model for refractory anastomotic stenosis after Ls-ISR. Based on the results of multivariate analysis, neoadjuvant therapy, distance from tumor to anal margin and clinic N staging were included to constructed the nomogram prediction model for refractory anastomotic stenosis after Ls-ISR. Results of ROC curve showed the AUC of nomogram prediction model for refractory anastomotic stenosis after Ls-ISR was 0.739 (95% confidence interval as 0.646-0.833).
    Conclusions Neoadjuvant therapy, distance from tumor to anal margin ≤4 cm, clinic N+ stage are independent risk factors of refractory anastomotic stenosis after Ls-ISR. Nomogram prediction model based on these factors can predict the incidence of refractory anastomotic stenosis after Ls-ISR.

     

/

返回文章
返回